Provision of Drug, Alcohol & DNA Testing Services Framework

Newport City Council · United Kingdom government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

$14.5M
Est. Value
Active
Status

Opportunity Overview

The Drug, Alcohol and DNA Testing Services framework established by Newport City Council in 2020 for use by Welsh local authorities is due to expire 30 September 2026.
The new framework which will commence on the 1 October 2026 will be comprised of 2 lots: Lot 1 - Drug & Alcohol Testing Services, Lot 2 - DNA Testing Services.
Suppliers appointed to the framework have to be accredited to ISO/IEC 17025:2017 standards and for Lot 2 must be UK Ministry of Justice approved.
The framework will be procured in accordance with the Light Touch Regime of the Procurement Act 2023.

This is one of 32 active United Kingdom Pharmaceuticals opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyNewport City Council
CountryUnited Kingdom
CategoryPharmaceuticals
Estimated value$14.5M
PublishedJune 25, 2026
Procurement stageRequest for Proposal (RFP)
Response dueNot specified / rolling
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedOctober 06, 2026

Contains public sector information licensed under the Open Government Licence v3.0. Source: UK Government (Find a Tender).

Related Opportunities in United Kingdom

Purchase, Storage and Emergency Production of Foot and Mouth Antigen and Vaccine
Drug Knowledge Base for Electronic Health and Care Record
Criminal Justice Related Drug and Alcohol Referral Service for Adults
Individual Placement & Support Service (IPS)
Personalised Adaptive Medicine
Development of PS Targeting Synthetic Protein Drug Conjugates As A Genetic Alteration Agnostic Cancer Therapy
Repurposing Epigenetic Therapy for Hypertrophic Cardiomyopathy to facilitate the innovation and growth of a N.Ireland Cardiac Drug Development Company
Contract for the Provision of Drug, Alcohol and DNA Testing Services

See every United Kingdom Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Pharmaceuticals intelligence report in your inbox

A personalized report on United Kingdom Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.